Robert Bain Thomas, Director at REVA Medical, Inc. (RVA), bought 2,500 shares at $8.42 ($21K) on 2016-03-31, disclosed to the SEC on 2016-04-04.
Open-market purchase of $21k RVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| RVA.AX | BUY | 2018-06-01 | $10K | — | Filing → |
| RVA.AX | BUY | 2018-03-30 | $15K | — | Filing → |
| RVA.AX | BUY | 2018-03-28 | $15K | — | Filing → |